{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T00:32:44Z","timestamp":1793320364842,"version":"4.5.0"},"reference-count":13,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T00:00:00Z","timestamp":1788393600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,10,30]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The discovery of Cystic Fibrosis Transmembrane conductance Regulator (CFTR) modulators has revolutionized the management and clinical outcomes of cystic fibrosis. However, the pleiotropic effects of these new treatments outside the lungs are still largely unknown. Here we report two unusual cases of acute kidney injury in patient with cystic fibrosis (pwCF) following a first exposure to aminoglycoside while under triple correction therapy. We hypothesize that CFTR modulator therapy restored the reabsorption of aminoglycoside in the proximal tubule of the kidneys, a process that is primarily deficient in patients with cystic fibrosis, thus exacerbating the toxicity of these molecules.<\/jats:p>","DOI":"10.1093\/joneph\/aajag182","type":"journal-article","created":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T11:37:01Z","timestamp":1782214621000},"page":"1709-1712","source":"Crossref","is-referenced-by-count":0,"title":["Acute kidney injury after aminoglycoside exposure in two cystic fibrosis patients receiving triple CFTR modulator therapy"],"prefix":"10.1093","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-2502-2475","authenticated-orcid":false,"given":"Deslais","family":"Martin","sequence":"first","affiliation":[{"name":"Nephrology Dept, Lyon Sud Hospital , Pierre-Benite ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8609-3572","authenticated-orcid":false,"given":"Novel-Catin","family":"Etienne","sequence":"additional","affiliation":[{"name":"Nephrology Dept, Lyon Sud Hospital , Pierre-Benite ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nove-Josserand","family":"Rapha\u00eble","sequence":"additional","affiliation":[{"name":"Hospices Civils de Lyon (HCL), Cystic Fibrosis Adult Reference Center, Department of Internal Medicine, Groupe Hospitalier Sud , Pierre Benite Cedex ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9707-7199","authenticated-orcid":false,"given":"Fouque","family":"Denis","sequence":"additional","affiliation":[{"name":"Nephrology Dept, Lyon Sud Hospital , Pierre-Benite ,","place":["France"]},{"name":"Universit\u00e9 Claude Bernard Lyon1 , Lyon ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Durieu","family":"Isabelle","sequence":"additional","affiliation":[{"name":"Hospices Civils de Lyon (HCL), Cystic Fibrosis Adult Reference Center, Department of Internal Medicine, Groupe Hospitalier Sud , Pierre Benite Cedex ,","place":["France"]},{"name":"INSERM U1290 RESHAPE Research in Health Care Performance, Lyon 1 Claude Bernard University , Lyon ,","place":["France"]},{"name":"Universit\u00e9 Claude Bernard Lyon1 , Lyon ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,9,3]]},"reference":[{"key":"2026102919573035800_aajag182-B1","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1016\/S0140-6736(09)60327-5","article-title":"Cystic fibrosis","volume":"373","author":"O'Sullivan","year":"2009","journal-title":"Lancet"},{"key":"2026102919573035800_aajag182-B2","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1016\/S0140-6736(20)32542-3","article-title":"Cystic fibrosis","volume":"397","author":"Shteinberg","year":"2021","journal-title":"Lancet"},{"key":"2026102919573035800_aajag182-B3","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1056\/NEJMoa1908639","article-title":"Elexacaftor\u2013tezacaftor\u2013ivacaftor for cystic fibrosis with a single Phe508del allele","volume":"381","author":"Middleton","year":"2019","journal-title":"N Engl J Med"},{"key":"2026102919573035800_aajag182-B4","doi-asserted-by":"publisher","first-page":"10513","DOI":"10.3390\/ijms262110513","article-title":"Real-world safety and effectiveness of elexacaftor, tezacaftor, and ivacaftor in people with cystic fibrosis and advanced lung disease: a two-year multicenter cohort study","volume":"26","author":"Volpi","year":"2025","journal-title":"Int J Mol Sci"},{"key":"2026102919573035800_aajag182-B5","doi-asserted-by":"publisher","first-page":"sfae256","DOI":"10.1093\/ckj\/sfae256","article-title":"Kidney effects of triple CFTR modulator therapy in people with cystic fibrosis","volume":"17","author":"Gabai","year":"2024","journal-title":"Clin Kidney J"},{"key":"2026102919573035800_aajag182-B6","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1097\/CCM.0000000000007075","article-title":"Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2026","volume":"54","author":"Prescott","year":"2026","journal-title":"Crit Care Med"},{"key":"2026102919573035800_aajag182-B7","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1590\/S0001-37652000000300013","article-title":"The Cystic Fibrosis Transmembrane Regulator (CFTR) in the kidney","volume":"72","author":"Morales","year":"2000","journal-title":"An Acad Bras Ci\u00eanc"},{"key":"2026102919573035800_aajag182-B8","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1126\/science.2475911","article-title":"Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA","volume":"245","author":"Riordan","year":"1989","journal-title":"Science"},{"key":"2026102919573035800_aajag182-B9","doi-asserted-by":"publisher","first-page":"4151","DOI":"10.1113\/JP270087","article-title":"Chloride transporters and receptor-mediated endocytosis in the renal proximal tubule","volume":"593","author":"Devuyst","year":"2015","journal-title":"J Physiol"},{"key":"2026102919573035800_aajag182-B10","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/ki.2010.337","article-title":"New insights into the mechanism of aminoglycoside nephrotoxicity: an integrative point of view","volume":"79","author":"Lopez-Novoa","year":"2011","journal-title":"Kidney Int"},{"key":"2026102919573035800_aajag182-B11","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1093\/ndt\/gfy084","article-title":"Aminoglycoside exposure and renal function before lung transplantation in adult cystic fibrosis patients","volume":"34","author":"Novel-Catin","year":"2019","journal-title":"Nephrol Dial Transplant"},{"key":"2026102919573035800_aajag182-B12","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1007\/s00424-011-1026-2","article-title":"Decreased renal accumulation of aminoglycoside reflects defective receptor-mediated endocytosis in cystic fibrosis and Dent's disease","volume":"462","author":"Raggi","year":"2011","journal-title":"Pflugers Arch"},{"key":"2026102919573035800_aajag182-B13","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1002\/ppul.22813","article-title":"Optimization of anti-pseudomonal antibiotics for cystic fibrosis pulmonary exacerbations: V. Aminoglycosides","volume":"48","author":"Young","year":"2013","journal-title":"Pediatr Pulmonol"}],"container-title":["Journal of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/joneph\/article-pdf\/39\/8\/1709\/70935309\/aajag182.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/joneph\/article-pdf\/39\/8\/1709\/70935309\/aajag182.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T23:57:36Z","timestamp":1793318256000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/joneph\/article\/39\/8\/1709\/8780933"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,3]]},"references-count":13,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,9,3]]},"published-print":{"date-parts":[[2026,10,30]]}},"URL":"https:\/\/doi.org\/10.1093\/joneph\/aajag182","relation":{},"ISSN":["1121-8428","1724-6059"],"issn-type":[{"value":"1121-8428","type":"print"},{"value":"1724-6059","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,11]]},"published":{"date-parts":[[2026,9,3]]}}}